Lava Therapeutics Boils Up Thanks to New Deal
Market News

Lava Therapeutics Boils Up Thanks to New Deal

Biotech stock Lava Therapeutics (NASDAQ:LVTX) is on a serious hot streak today. So far, it’s up on a double-digit surge and climbing. The big reason for the climb is simple: a new deal with Johnson & Johnson (NYSE:JNJ) and its Janssen Biotech unit that could see a whole new cancer treatment get underway.

Back in 2020, Lava got together with Janssen to work on a new antibody system that would ultimately target gamma-delta T cells. Such a substance would make it, quite possibly, a big name in fighting cancer. Now, Janssen has chosen such a candidate for further development and will now be the leader in developing, producing, and marketing the result.

Lava Therapeutics’ president and CEO, Stephen Hurly, noted that Lava was “…pioneering the development of gamma-delta bispecific antibodies to treat cancer through our proprietary Gammabody platform…” The treatment in question will continue to be developed and passed through clinical testing. Hopefully, not long after that, a viable treatment will emerge.

Lava Therapeutics has already proven attractive to analysts. Four Buy ratings make it a Strong Buy by unanimous analyst consensus. Further, with an average price target of $12.50 per share, Lava Therapeutics stock offers investors a 275.38% upside potential.

Disclosure

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
RUT
Russell 2000
TNX
10-Yr-Bond
Bitcoin

Popular Articles